(3aS,4R,6aR)-6-[(Benzyloxy)methyl]-5-fluoro-2,2-dimethyl-2H,3aH,4H,6aH-cyclopenta[d][1,3]dioxol-4-ol, 95+%, 500mg

4-(5-Bromopyridin-3-yl)morpholine, 95.0%, 10g

(R)-2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxaldehyde, 97%, 100mg

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98.0%, 5g

5-Chloro-2-methylphenol, 98.0%, 1g

3-(1-Oxo-1,3-dihydro-isoindol-2-yl)-propionic acid, 95.0%, 5g

2-(1-methyl-1H-imidazol-2-yl)piperidine, 95.0%, 250mg

5-Norbornene-2-carboxylic Acid (endo- and exo- mixture)>98.0%(GC)(T)25g

Methyl 2-(4-fluoro-3-nitrophenyl)acetate, 95.0%, 25g

2-Amino-4-chloro-6-fluorobenzothiazole, 95.0%, 250mg

2-Amino-2-phenylethanol, 98.0%, 500g

MEthyl[(2S)-pyrrolidin-2-ylmethyl]amine, 96%, 250mg

1-(5-NITROPYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE, 97.0%, 5g